This Week, Top Geneticists Want to Decide If GMO Humans Are OK
By Alex Pearlman,
VICE Motherboard
| 12. 02. 2015
[cites CGS’ Marcy Darnovsky]
Untitled Document
The world’s top geneticists met in Washington, DC Tuesday to discuss the future of human genome editing at a summit that is among the most important ever held on the topic. By Thursday, the group hopes to decide on a tentative path forward for potential human applications of powerful gene editing techniques such as CRISPR/Cas9, which can target and modify DNA with great specificity.
CRISPR has been hugely hyped for its potential to create safer, more precise genetically modified organisms—its promoters have suggested that we could de-extinct animals, modify mosquitoes to naturally eradicate malaria, and create drought- and heat-resistant crops for a world that’s increasingly threatened by climate change, for example. But the potential applications for CRISPR don’t stop there, of course. There’s reason to believe that scientists could edit the human genome to end genetic disease, make us live longer, and create designer babies.
Experiments on nonviable human embryos started in China earlier this year, meaning we may be close to a future where any organism can be edited. Any talk of editing humans comes with...
Related Articles
By Courtney Withers and Daryna Zadvirna, ABC News | 12.03.2025
Same-sex couples, single people, transgender and intersex West Australians will be able to access assisted reproductive technology (ART) and surrogacy, almost a decade after reforms were first promised.
The landmark legislation, which removes the requirement for people to demonstrate medical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...